{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T16:39:03Z","timestamp":1780331943032,"version":"3.54.1"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007660","name":"University of Antwerp","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007660","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.cca.2022.03.005","type":"journal-article","created":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T02:07:46Z","timestamp":1646878066000},"page":"4-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Proline-specific peptidase activities (DPP4, PRCP, FAP and PREP) in plasma of hospitalized COVID-19 patients"],"prefix":"10.1016","volume":"531","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4584-3082","authenticated-orcid":false,"given":"An","family":"Bracke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"De Hert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"De bruyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Claesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwendolyn","family":"Vliegen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Vujkovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lida","family":"van Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fien H.R.","family":"De Winter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An","family":"Hotterbeekx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Brosius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Theunissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Van Ierssel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maartje","family":"van Frankenhuijsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Vlieghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen","family":"Vercauteren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter","family":"Van der Veken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Hendriks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir","family":"Kumar-Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"De Meester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2022.03.005_b0005","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2022.03.005_b0010","unstructured":"WHO web page, (2021). https:\/\/covid19.who.int\/ (accessed November 23, 2021)."},{"key":"10.1016\/j.cca.2022.03.005_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2015.00387","article-title":"The dipeptidyl peptidase family, prolyl oligopeptidase and prolyl carboxypeptidase in the immune system and inflammatory disease, including atherosclerosis","volume":"6","author":"Waumans","year":"2015","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.cca.2022.03.005_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0231555","article-title":"Dysregulated activities of proline-specific enzymes in septic shock patients (sepsis-2)","volume":"15","author":"Vliegen","year":"2020","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cca.2022.03.005_b0025","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.2337\/dc07-0228","article-title":"Dipeptidyl Peptidase-4 Inhibition and the Treatment of Type 2 Diabetes","volume":"30","author":"Drucker","year":"2007","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.cca.2022.03.005_b0030","doi-asserted-by":"crossref","first-page":"6874","DOI":"10.1073\/pnas.120069197","article-title":"Enhanced insulin secretion and improved glucose tolerance in mice lacking CD26","volume":"97","author":"Marguet","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.cca.2022.03.005_b0035","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.cmet.2016.10.007","article-title":"Cellular Sites and Mechanisms Linking Reduction of Dipeptidyl Peptidase-4 Activity to Control of Incretin Hormone Action and Glucose Homeostasis","volume":"25","author":"Mulvihill","year":"2017","journal-title":"Cell Metab."},{"key":"10.1016\/j.cca.2022.03.005_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2020.01161","article-title":"DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications?","volume":"11","author":"Valencia","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"12","key":"10.1016\/j.cca.2022.03.005_b0045","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1038\/nm.2991","article-title":"Dipeptidylpeptidase 4 negatively regulates colony-stimulating factor activity and stress hematopoiesis","volume":"18","author":"Broxmeyer","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.cca.2022.03.005_b0050","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0014-5793(98)00830-8","article-title":"Processing by CD26\/dipeptidyl-peptidase IV reduces the chemotactic and anti-HIV-1 activity of stromal-cell-derived factor-1\u03b1","volume":"432","author":"Proost","year":"1998","journal-title":"FEBS Lett."},{"key":"10.1016\/j.cca.2022.03.005_b0055","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.peptides.2006.09.027","article-title":"Neuropeptide Y (NPY) cleaving enzymes: Structural and functional homologues of dipeptidyl peptidase 4","volume":"28","author":"Frerker","year":"2007","journal-title":"Peptides"},{"issue":"1","key":"10.1016\/j.cca.2022.03.005_b0060","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s00125-011-2213-6","article-title":"High mobility group box 1 is a novel substrate of dipeptidyl peptidase-IV","volume":"55","author":"Marchetti","year":"2012","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.cca.2022.03.005_b0065","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1172\/JCI40594","article-title":"Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV","volume":"121","author":"Casrouge","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cca.2022.03.005_b0070","unstructured":"E. Ward, Dipeptidyl (amino) peptidase IV and Aminopeptidase Circulating Substance P in Vivo1, (1992)."},{"key":"10.1016\/j.cca.2022.03.005_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2016.00483","article-title":"Regulation of chemokine activity - A focus on the role of dipeptidyl peptidase IV\/CD26","volume":"7","author":"Metzemaekers","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cca.2022.03.005_b0080","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/713609354","article-title":"Dipeptidyl-peptidase IV from bench to bedside: An update on structural properties, functions, and clinical aspects of the enzyme DPP IV","volume":"40","author":"Lambeir","year":"2003","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"issue":"7440","key":"10.1016\/j.cca.2022.03.005_b0085","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nature12005","article-title":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC","volume":"495","author":"Raj","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.cca.2022.03.005_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/molecules25225392","article-title":"A Novel Purification Procedure for Active Recombinant Human DPP4 and the Inability of DPP4 to Bind SARS-CoV-2","volume":"25","author":"Xi","year":"2020","journal-title":"Molecules"},{"issue":"11","key":"10.1016\/j.cca.2022.03.005_b0095","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1016\/j.biocel.2004.05.006","article-title":"Purification, identification and characterisation of seprase from bovine serum","volume":"36","author":"Collins","year":"2004","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.cca.2022.03.005_b0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178987","article-title":"Circulating fibroblast activation protein activity and antigen levels correlate strongly when measured in liver disease and coronary heart disease","volume":"12","author":"Uitte de Willige","year":"2017","journal-title":"PLoS ONE"},{"issue":"7774","key":"10.1016\/j.cca.2022.03.005_b0105","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-019-1546-z","article-title":"Targeting Cardiac Fibrosis with Engineered T cells","volume":"573","author":"Aghajanian","year":"2019","journal-title":"Nature"},{"issue":"32","key":"10.1016\/j.cca.2022.03.005_b0110","doi-asserted-by":"crossref","first-page":"4343","DOI":"10.1038\/s41388-018-0275-3","article-title":"Pro-tumorigenic roles of fibroblast activation protein in cancer: back to the basics","volume":"37","author":"Pur\u00e9","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.cca.2022.03.005_b0115","doi-asserted-by":"crossref","unstructured":"J.A. Garc\u00eda-Horsman, The role of prolyl oligopeptidase, understanding the puzzle, Ann. Transl. Med. 8 (2020) 983\u2013983. 10.21037\/atm-20-3412.","DOI":"10.21037\/atm-20-3412"},{"issue":"1-2","key":"10.1016\/j.cca.2022.03.005_b0120","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jneuroim.2009.09.020","article-title":"Neutrophils contain prolyl endopeptidase and generate the chemotactic peptide, PGP, from collagen","volume":"217","author":"O'Reilly","year":"2009","journal-title":"J. Neuroimmunol."},{"issue":"5","key":"10.1016\/j.cca.2022.03.005_b0125","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1161\/01.HYP.0000126172.01673.84","article-title":"Prolyl Oligopeptidase Is Involved in Release of the Antifibrotic Peptide Ac-SDKP","volume":"43","author":"Cavasin","year":"2004","journal-title":"Hypertension"},{"issue":"2020","key":"10.1016\/j.cca.2022.03.005_b0130","first-page":"173","article-title":"Ang II (Angiotensin II) Conversion to Angiotensin-(1\u20137) in the Circulation Is POP (Prolyloligopeptidase)-Dependent and ACE2 (Angiotensin-Converting Enzyme 2)-Independent","volume":"75","author":"Serfozo","year":"1979","journal-title":"Hypertens. (Dallas, Tex."},{"issue":"17","key":"10.1016\/j.cca.2022.03.005_b0135","doi-asserted-by":"crossref","first-page":"5927","DOI":"10.1016\/S0021-9258(17)34557-X","article-title":"Purification and properties of prolylcarboxypeptidase (angiotensinase C) from human kidney","volume":"253","author":"Odya","year":"1978","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cca.2022.03.005_b0140","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.yfrne.2010.09.001","article-title":"New aspects of melanocortin signaling: A role for PRCP in \u03b1-MSH degradation","volume":"32","author":"Diano","year":"2011","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.cca.2022.03.005_b0145","first-page":"1481","article-title":"Prolyl carboxypeptidase purified from human placenta: its characterization and identification as an apelin-cleaving enzyme","volume":"2016","author":"Kehoe","year":"1864","journal-title":"Biochim. Biophys. Acta - Proteins Proteomics."},{"key":"10.1016\/j.cca.2022.03.005_b0150","first-page":"2291","article-title":"Prolylcarboxypeptidase regulates food intake by inactivating \u03b1-MSH in rodents","volume":"119","author":"Wallingford","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cca.2022.03.005_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114738","article-title":"The C-terminal cleavage of angiotensin II and III is mediated by prolyl carboxypeptidase in human umbilical vein and aortic endothelial cells","author":"De Hert","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cca.2022.03.005_b0160","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA - J. Am. Med. Assoc."},{"issue":"5","key":"10.1016\/j.cca.2022.03.005_b0165","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1021\/ml300410d","article-title":"Selective Inhibitors of Fibroblast Activation Protein (FAP) with a (4-Quinolinoyl)-glycyl-2-cyanopyrrolidine Scaffold","volume":"4","author":"Jansen","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.cca.2022.03.005_b0170","doi-asserted-by":"crossref","unstructured":"K. Jansen, L. Heirbaut, R. Verkerk, J.D. Cheng, J. Joossens, P. Cos, L. Maes, A. Lambeir, I. De Meester, K. Augustyns, P. Van Der Veken, Extended structure-activity relationship and pharmacokinetic investigation of (4-quinolinoyl) -glycyl- 2-cyanopyrrolidine inhibitors of fibroblast activation protein (FAP) (2014). 10.1021\/jm500031w.","DOI":"10.1021\/jm500031w"},{"key":"10.1016\/j.cca.2022.03.005_b0175","unstructured":"World Health Organization: Country & technical guidance \u2013 coronavirus disease (COVID-19). 2020, (n.d.). https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/technical-guidance (accessed December 17, 2021)."},{"issue":"3-4","key":"10.1016\/j.cca.2022.03.005_b0180","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.cca.2011.10.031","article-title":"Method comparison of dipeptidyl peptidase IV activity assays and their application in biological samples containing reversible inhibitors","volume":"413","author":"Matheeussen","year":"2012","journal-title":"Clin. Chim. Acta."},{"key":"10.1016\/j.cca.2022.03.005_b0185","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.cca.2019.04.063","article-title":"The development and validation of a combined kinetic fluorometric activity assay for fibroblast activation protein alpha and prolyl oligopeptidase in plasma","volume":"495","author":"Bracke","year":"2019","journal-title":"Clin. Chim. Acta."},{"issue":"2","key":"10.1016\/j.cca.2022.03.005_b0190","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ab.2013.09.002","article-title":"Validation of a specific prolylcarboxypeptidase activity assay and its suitability for plasma and serum measurements","volume":"443","author":"Kehoe","year":"2013","journal-title":"Anal. Biochem."},{"issue":"4","key":"10.1016\/j.cca.2022.03.005_b0195","doi-asserted-by":"crossref","first-page":"3926","DOI":"10.1016\/j.ijcard.2013.06.061","article-title":"Circulating concentrations of fibroblast activation protein \u03b1 in apparently healthy individuals and patients with acute coronary syndrome as assessed by sandwich ELISA","volume":"168","author":"Tillmanns","year":"2013","journal-title":"Int. J. Cardiol."},{"issue":"2","key":"10.1016\/j.cca.2022.03.005_b0200","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s12975-016-0493-3","article-title":"Acute Ischemic Stroke Severity, Progression, and Outcome Relate to Changes in Dipeptidyl Peptidase IV and Fibroblast Activation Protein Activity","volume":"8","author":"Baerts","year":"2017","journal-title":"Transl. Stroke Res."},{"key":"10.1016\/j.cca.2022.03.005_b0205","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ijcard.2014.10.091","article-title":"Plasma levels of soluble fibroblast activation protein in arterial thrombosis; Determinants and cleavage of its substrate alpha-2-antiplasmin","volume":"178","author":"Uitte De Willige","year":"2015","journal-title":"Int. J. Cardiol."},{"issue":"5","key":"10.1016\/j.cca.2022.03.005_b0210","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1155\/2012\/706745","article-title":"Plasma seprase and DPP4 levels as markers of disease and prognosis in cancer","volume":"32","author":"Javidroozi","year":"2012","journal-title":"Dis. Markers."},{"key":"10.1016\/j.cca.2022.03.005_b0215","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1084\/jem.20122344","article-title":"Depletion of stromal cells expressing fibroblast activation protein-\u03b1 from skeletal muscle and bone marrow results in cachexia and anemia","volume":"210","author":"Roberts","year":"2013","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cca.2022.03.005_b0220","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/j.1365-2141.2008.07241.x","article-title":"Fibroblast activation protein \u03b1 identifies mesenchymal stromal cells from human bone marrow","volume":"142","author":"Bae","year":"2008","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.cca.2022.03.005_b0225","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1084\/jem.20130110","article-title":"Immune targeting of fibroblast activation protein triggers recognition of multipotent bone marrow stromal cells and cachexia","volume":"210","author":"Tran","year":"2013","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cca.2022.03.005_b0230","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/ni.3002","article-title":"Plasticity of mesenchymal stem cells in immunomodulation: Pathological and therapeutic implications","volume":"15","author":"Wang","year":"2014","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cca.2022.03.005_b0235","article-title":"Regulation of Inflammatory Cytokine Storms by Mesenchymal Stem Cells","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cca.2022.03.005_b0240","doi-asserted-by":"crossref","unstructured":"A.A. Fitzgerald, E.F. Marcisak, A. Nasir, E. Glasgow, S.J. Jablonski, P. Van Der Veken, G. Pearson, E.J. Fertig, E.M. Mace, L.M. Weiner, Fibroblast activation protein regulates natural killer cell migration, extravasation and tumor infiltration, BioRxiv. (2021) 2021.02.03.429622. 10.1101\/2021.02.03.429622.","DOI":"10.1101\/2021.02.03.429622"},{"key":"10.1016\/j.cca.2022.03.005_b0245","article-title":"Exhausted NK cells and cytokine storms in COVID-19: Whether NK cell therapy could be a therapeutic choice","author":"Ghasemzadeh","year":"2021","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.cca.2022.03.005_b0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12891-015-0707-y","article-title":"Intraindividual changes of dipeptidyl peptidase-IV in peripheral blood of patients with rheumatoid arthritis are associated with the disease activity Clinical rheumatology and osteoporosis","volume":"16","author":"Sromova","year":"2015","journal-title":"BMC Musculoskelet. Disord."},{"issue":"2","key":"10.1016\/j.cca.2022.03.005_b0255","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.clim.2013.11.011","article-title":"Low DPP4 expression and activity in multiple sclerosis","volume":"150","author":"Tejera-Alhambra","year":"2014","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.cca.2022.03.005_b0260","doi-asserted-by":"crossref","unstructured":"M.R. M. Hildebrandt J. R\u00fcter, A. Salama, H. M\u00f6nnikes, B. F. Klapp, Dipeptidyl Peptidase IV (DP IV, CD26) in Patients with Inflammatory Bowel Disease, Scand. J. Gastroenterol. 36 (2001) 1067\u20131072. 10.1080\/003655201750422675.","DOI":"10.1080\/003655201750422675"},{"issue":"11","key":"10.1016\/j.cca.2022.03.005_b0265","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1007\/s00262-009-0728-1","article-title":"On the origin of serum CD26 and its altered concentration in cancer patients","volume":"58","author":"Cordero","year":"2009","journal-title":"Cancer Immunol. Immunother."},{"issue":"5","key":"10.1016\/j.cca.2022.03.005_b0270","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s40618-020-01392-5","article-title":"Circulating dipeptidyl peptidase-4 is independently associated with the presence and severity of NAFLD\/NASH in individuals with and without obesity and metabolic disease","volume":"44","author":"Barchetta","year":"2021","journal-title":"J. Endocrinol. Invest."},{"issue":"6","key":"10.1016\/j.cca.2022.03.005_b0275","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.hlc.2020.11.008","article-title":"The Counter Regulatory Axis of the Lung Renin-Angiotensin System in Severe COVID-19: Pathophysiology and Clinical Implications","volume":"30","author":"Triposkiadis","year":"2021","journal-title":"Hear. Lung Circ."},{"key":"10.1016\/j.cca.2022.03.005_b0280","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1373\/clinchem.2011.179291","article-title":"Plasma prolylcarboxypeptidase (angiotensinase C) is increased in obesity and diabetes mellitus and related to cardiovascular dysfunction","volume":"58","author":"Xu","year":"2012","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cca.2022.03.005_b0285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0197603","article-title":"Prolyl carboxypeptidase activity in the circulation and its correlation with body weight and adipose tissue in lean and obese subjects","volume":"13","author":"Kehoe","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.cca.2022.03.005_b0290","doi-asserted-by":"crossref","unstructured":"G. Vliegen, T.K. Raju, D. Adriaensen, A.M. Lambeir, I. de Meester, The expression of proline-specific enzymes in the human lung, Ann. Transl. Med. 5 (2017) 1\u201313. 10.21037\/atm.2017.03.36.","DOI":"10.21037\/atm.2017.03.36"},{"issue":"3","key":"10.1016\/j.cca.2022.03.005_b0295","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.pharmthera.2012.07.012","article-title":"Dipeptidyl peptidase 4 as a therapeutic target in ischemia\/reperfusion injury","volume":"136","author":"Matheeussen","year":"2012","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.cca.2022.03.005_b0300","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.3390\/ijms222111886","article-title":"The protective role of prolyl oligopeptidase (Pop) inhibition in kidney injury induced by renal ischemia\u2013reperfusion","volume":"22","author":"Casili","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cca.2022.03.005_b0305","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2967\/jnumed.121.261925","article-title":"Fibroblast Activation Protein-Specific PET\/CT Imaging in Fibrotic Interstitial Lung Diseases and Lung Cancer: A Translational Exploratory Study","volume":"63","author":"R\u00f6hrich","year":"2022","journal-title":"J. Nucl. Med."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898122000869?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898122000869?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:02:51Z","timestamp":1757862171000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898122000869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":61,"alternative-id":["S0009898122000869"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2022.03.005","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proline-specific peptidase activities (DPP4, PRCP, FAP and PREP) in plasma of hospitalized COVID-19 patients","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2022.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}